Emerald BioStructures Leads International Consortium to Crystallize Key Parkinson's Disease Enzyme

Published: Dec 09, 2010

BAINBRIDGE ISLAND, Wash.--(BUSINESS WIRE)--Emerald BioStructures, a leading provider of integrated structural biology services, has received funding from The Michael J. Fox Foundation for Parkinson’s Research to lead a consortium working to crystallize and solve the structure of the enzyme believed to be a key molecular mechanism behind Parkinson’s disease.

Back to news